检索结果 - Mansaray, Rahmatu

Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: A case report 由 Glitza, Isabella C., Haymaker, Cara, Bernatchez, Chantale, Vence, Luis, Rohlfs, Michelle, Richard, Jessie, Lacey, Carol, Mansaray, Rahmatu, Fulbright, Orenthial J., Ramachandran, Renjith, Toth, Christopher, Wardell, Seth, Patel, Sapna P., Woodman, Scott E., Hwu, Wen-Jen, Radvanyi, Laszlo G., Davies, Michael A., Papadopoulos, Nicholas E., Hwu, Patrick

获取全文 获取全文 获取全文

Utilizing T-cell activation signals 1, 2 and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma 由 Tavera, René J., Forget, Marie-Andrée, Kim, Young Uk, Sakellariou-Thompson, Donastas, Creasy, Caitlin A., Bhatta, Ankit, Fulbright, Orenthial J., Ramachandran, Renjith, Thorsen, Shawne T., Flores, Esteban, Wahl, Arely, Gonzalez, Audrey M., Toth, Christopher, Wardell, Seth, Mansaray, Rahmatu, Radvanyi, Laszlo G., Gombos, Dan S., Patel, Sapna P., Hwu, Patrick, Amaria, Rodabe N., Bernatchez, Chantale, Haymaker, Cara

获取全文 获取全文 获取全文

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients 由 Radvanyi, Laszlo G., Bernatchez, Chantale, Zhang, Minying, Fox, Patricia S., Miller, Priscilla, Chacon, Jessica, Wu, Richard, Lizee, Gregory, Mahoney, Sandy, Alvarado, Gladys, Glass, Michelle, Johnson, Valen E., McMannis, John D., Shpall, Elizabeth, Prieto, Victor, Papadopoulos, Nicholas, Kim, Kevin, Homsi, Jade, Bedikian, Agop, Hwu, Wen-Jen, Patel, Sapna, Ross, Merrick I., Lee, Jeffrey E., Gershenwald, Jeffrey E., Lucci, Anthony, Royal, Richard, Cormier, Janice N., Davies, Michael A., Mansaray, Rahmatu, Fulbright, Orenthial J., Toth, Christopher, Ramachandran, Renjith, Wardell, Seth, Gonzalez, Audrey, Hwu, Patrick

获取全文 获取全文 获取全文

Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome 由 Forget, Marie-Andrée, Haymaker, Cara, Hess, Kenneth R., Meng, Yuzhong Jeff, Creasy, Caitlin, Karpinets, Tatiana, Fulbright, Orenthial J., Roszik, Jason, Woodman, Scott E., Kim, Young Uk, Sakellariou-Thompson, Donastas, Bhatta, Ankit, Wahl, Arely, Flores, Esteban, Thorsen, Shawne T., Tavera, René J., Ramachandran, Renjith, Gonzalez, Audrey M., Toth, Christopher L., Wardell, Seth, Mansaray, Rahmatu, Patel, Vruti, Carpio, Destiny Joy, Vaughn, Carol, Farinas, Chantell M., Velasquez, Portia G., Hwu, Wen-Jen, Patel, Sapna P., Davies, Michael A., Diab, Adi, Glitza, Isabella C., Tawbi, Hussein, Wong, Michael K., Cain, Suzanne, Ross, Merrick I., Lee, Jeffrey E., Gershenwald, Jeffrey E., Lucci, Anthony, Royal, Richard, Cormier, Janice N., Wargo, Jennifer A., Radvanyi, Laszlo G., Torres-Cabala, Carlos A., Beroukhim, Rameen, Hwu, Patrick, Amaria, Rodabe N., Bernatchez, Chantale

获取全文 获取全文 获取全文